Clinical Trials Logo

Clinical Trial Summary

The main objective of the study is to show that the addition of ultrasonography to the dual tracer scintigraphy MIBI-Tc99m/Iodine-123 will increase (at least +5%) the negative predictive value compared to the dual tracer scintigraphy alone in detection of malignancy in thyroid nodules ≥15 mm classified as Bethesda III-IV on cytology.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03498183
Study type Interventional
Source Nantes University Hospital
Contact Eric Mirallié, MD
Email eric/mirallie@chu-nantes.fr
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date July 1, 2018
Completion date July 1, 2021